15 The overall malaria burden in the Americas has decreased dramatically over the past two 16 decades, but residual transmission pockets persist across the Amazon Basin, where 17 Plasmodium vivax is the predominant infecting species. Current elimination efforts require a 18 better quantitative understanding of malaria transmission dynamics for planning, monitoring, 19 and evaluating interventions at the community level. This can be achieved with mathematical 20 models that properly account for risk heterogeneity in communities approaching elimination, 21 where few individuals disproportionately contribute to overall malaria prevalence, morbidity, 22 and onwards transmission. Here we analyse demographic information combined with 23 routinely collected malaria morbidity data from the town of Mâncio Lima, the main urban 24 transmission hotspot of Brazil. We estimate the proportion of high-risk subjects in the host 25 population by fitting compartmental susceptible-infected-susceptible (SIS) transmission 26 models simultaneously to age-stratified vivax malaria incidence densities and the frequency 27 distribution of P. vivax malaria attacks experienced by each individual over 12 months.
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155 Individuals do not move between LR and HR groups and, within each risk group, they are 156 classified as either susceptible or infected. Each risk group comprises a proportion (0 < 157 and ) of the total population and is associated with a risk factor < 1, = 1, 2 1 + 2 = 1 158 ( ). Without loss of generality, we assume that the overall average risk is equal to > 0 = 1, 2 159 1 ( ) since the factors are modifiers of individual responses to a force of 1 1 + 2 2 = 1 160 infection which will be allowed to vary. This setting configures a risk distribution with variance 169 force of infection modified by a risk factor , and a partial immunity weight ; all ( ) ( ) 170 individuals recover at the same rate .
172
We assume an age-dependent force of infection (Equation 1), which correlates mosquito ( ) 173 biting activity with human body mass [18, 19] . This function strictly increases with age, with 174 minimum (at age zero) and upper limit . The parameter determines how steeply 0 (1 -) 0 175 the force of infection increases in early ages and controls the value at birth.
176
( ) = 0 (1 --)
10 178 Assuming that individuals acquire partial immunity after repeated clinical malaria attacks, due 179 to antibody-and cell-mediated responses [20] , we introduce a factor describing the 180 development of partial immunity. The strictly positive decreasing function of the number ( )
181
( ) of past clinical vivax malaria attacks each individual has experienced (Equation 2), with ≥ 0 182 a maximum for malaria-naïve individuals ( ), simulates a partial immunity factor and (0) = 1 183 weights down the age-dependent force of infection as the number of cumulative clinical ( ) 184 malaria episodes increases. The factor describing partial immunity is controlled by the 185 parameter which determines the rate at which immunity develops after repeated infections. ,
The transmission dynamics with age-dependent force of infection, partial immunity acquisition 189 and risk heterogeneity, in equilibrium with respect to time, is formalised by the system of 190 ordinary differential equations (ODEs) in age domain (system of equations 3). 202 the LR group. With similar dynamics, HR individuals move forward within the HR group, but 203 with a risk factor (Fig 1) . This is denominated as the heterogeneous risk model. . This approach contrasts with previous attempts to fit similar SIS models
221 to age-related malaria prevalence or incidence data in that we also consider the overall 
in which is the model output for age-specific malaria incidence densities, is the model 234 output for the number of cases per person over 12 months, is the standard deviation of the 1 235 measurement noise for , and is the standard deviation of the measurement noise for . 246 We next incorporated into the model compartments comprising infected but asymptomatic 247 individuals, by assuming that the proportion of asymptomatic infections depends on gradually 248 acquired partial immunity. This partial immunity is sometimes termed "clinical" or "anti-249 disease immunity" to emphasise that individuals remain susceptible to infection but become 250 gradually less likely to develop clinical disease once infected. We followed the same basic 334 We first fitted empirical data by using a compartmental SIS model that considers the entire 335 host population as being homogeneously at risk of clinical vivax malaria, with x = 1 (Fig 3C) . The 336 simultaneous fitting to empirical profiles of incidence by age and number of annual episodes 337 per person is optimal when the age-dependent force of infection (Equation 1) takes parameter 338 values , and (Fig 3D) and the partial immunity factor 0 = 0.7452 = 0.8787 = 0.0282 339 (Equation 2) decays at constant rate per infection experienced (Fig 3E) . The = 0.1162 340 homogeneous-risk model output recapitulates how malaria incidence density varies with age 341 (Fig 3A; see also [21]) but does not satisfactorily fit the number of episodes per person over 342 the one-year follow-up (Fig 3B) . The best-fitting solution obtained with the heterogeneous model is presented in Fig 4. Fig 4A   361 compares empirical age-specific malaria incidence data to the model output, which combines 362 incidence densities in the LR and HR groups. Overall, the HR group is estimated to contribute 363 86.0% of the overall vivax malaria burden in the community, roughly as expected from the 364 "20/80 rule" [1] . High-risk individuals become infected earlier and acquire partial immunity 365 faster than their low-risk counterparts, resulting in markedly different, subgroup-specific age-366 incidence patterns. In the HR group, the incidence of clinical malaria sharply increases with age 367 among children and adolescents, but declines thereafter; in contrast, malaria incidence density 368 increases slowly in the LR group and reaches a plateau in the fourth decade of life. Fig 4B shows 19 369 that the model properly fits the empirical frequency distribution of cases per person 
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383 Fig 4C, Fig 4D and Fig 4E show, respectively 398 We next solve the model incorporating a compartment with individuals who are infected but 399 asymptomatic. The dynamics of individuals through model compartments, considering that 400 asymptomatic infections last an average of 90 days (i.e. = 1/90 per day), is shown in Fig 5. ' 401 Individuals in the LR group move slowly between compartments (Fig 5A, Fig 5B and Fig 5C) , 402 compared with their HR counterparts (Fig 5D, Fig 5E and Fig 5F) . Using the population age 403 structure determined by our census survey, the model predicts that, in the current population, Because the asymptomatic infection recovery rate is unknown, we assumed the average ' 417 duration of asymptomatic parasite carriage ( ) to range from 30 to 60 and 180 days ( Fig 6) .
418 Model outputs recapitulate the age-dependent increase in the prevalence of asymptomatic P.
419 vivax carriage that has been described in Amazonian communities (Fig 6A; e.g., [35] ) and, as 420 expected, indicate that the community-wide prevalence of asymptomatic P. vivax infection 421 increases with longer parasite carriage duration ( Fig 6B) . Importantly, model simulations 
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434 The relative contribution of asymptomatic and symptomatic infections to the overall burden 435 of P. vivax infection in the community was also simulated (Fig 7) . We observe that, even with 436 short-lived asymptomatic parasite carriage ( days), 66-85% of subjects carrying = 1 ' = 30 437 P. vivax infection at a given time will be asymptomatic, consistent with empirical estimates 438 from across the Amazon ranging between 52% and 90% [32, [35] [36] [37] . We note that these 439 empirical data can be used to estimate and in the target populations. 455 87% of the infectious reservoir if IR ranges between 1/2 and 1/10 ( Figs 8B and 8E) , with a minor 456 further increase with days ( Fig 8C and 8F) . We further note that, for most and RI = 180 457 value combinations, the relative contribution of symptomatic infections to the infectious 458 reservoir can be substantially reduced by providing prompt CQ-PQ treatment to reduce the 459 mean gametocyte clearance time (or average duration of infectiousness) from 12 to 4 days. 
